Acquisitions, Investments, and Licenses - Summary of Pro Forma Results (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2015 |
Dec. 31, 2014 |
|
EirGen Pharma Limited | ||
Business Acquisition [Line Items] | ||
Revenues | $ 495,993 | $ 105,973 |
Net loss | (32,481) | (176,563) |
Net loss attributable to common shareholders | (31,081) | (173,590) |
Bio-Reference Laboratories, Inc. | ||
Business Acquisition [Line Items] | ||
Revenues | 1,052,462 | 923,407 |
Net loss | (19,456) | (140,854) |
Net loss attributable to common shareholders | $ (18,055) | $ (137,881) |